Day: February 18, 2021

TORONTO, Feb. 18, 2021 (GLOBE NEWSWIRE) — COIN Hodl Inc. (TSXV: COIN) (“COIN”) is pleased to announce it has entered into a binding agreement with a royalty company pursuant to which COIN will sell its royalty interest (the “Royalty”) on certain mining concessions located in the Province of San Juan, Argentina (the “Del Carmen Project”), for cash consideration of C$1,600,000.The Royalty is a 0.5% net smelter returns royalty in respect of products mined from the Del Carmen Project which was granted to COIN under a royalty agreement with Minera Del Carmen S.A., dated April 6, 2015.The sale of the Royalty remains subject to satisfaction of customary conditions, approval of the TSX Venture Exchange (the “Exchange”) and execution of standard transaction documentation.No finder’s fees are payable in connection with the sale of the Royalty.Update...

Not for distribution to the U.S. newswire or for dissemination in the United StatesTORONTO, Feb. 18, 2021 (GLOBE NEWSWIRE) — SOPerior Fertilizer Corp. (“SOP” or the “Company”) (TSX:SOP) announces that effective February 22, 2021, the Company’s shares will begin trading on the NEX Board (“NEX”) of the TSX Venture Exchange (“the Exchange”) under the symbol SOP.H.The Company will delist from trading on the Toronto Stock Exchange effective at the close on February 19, 2021. The Company no longer meets Toronto Stock Exchange minimum listing requirements and also does not meet the requirements of a TSX Venture Tier 2 company.On Behalf of the Board of DirectorsSOPERIOR FERTILIZER CORP.“Andrew Squires”Chief Executive OfficerContact InformationE-mail inquiries: info@SOPfertilizer.comP: (403) 850-0422NEITHER THE TORONTO STOCK EXCHANGE, NEX...

EAST GREENVILLE, Pa., Feb. 18, 2021 (GLOBE NEWSWIRE) — Knoll, Inc. (NYSE: KNL) — Research by Knoll, Inc., a constellation of design-driven brands and people, working together with clients in person and digitally to create inspired modern interiors for workplaces and homes, has found that over the next 18–24 months workplace design will accelerate away from individual workspaces to a reallocation of space for meeting spaces, social spaces and outdoor spaces.The finding supports the Knoll perspective that considers the emerging post-Covid pandemic workplace as an ecosystem supporting flexibility as to where and when one works but, importantly, weighted toward in-office collaborative activity. The Thriving Workplace celebrates this workplace design model, prioritizing brand values and organizational culture.Based on fourth quarter...

SALT LAKE CITY, Feb. 18, 2021 (GLOBE NEWSWIRE) — ZAGG Inc (Nasdaq: ZAGG) (“we,” “us,” “our,” “ZAGG,” or the “Company”), a leading global mobile lifestyle company, today announced that its stockholders voted to adopt the previously announced definitive merger agreement in which ZAGG will be acquired by a buyer group led by Evercel, Inc. (“Evercel”) at its special meeting of stockholders held earlier today.   At the special meeting, ZAGG stockholders adopted the merger agreement with more than 56% of the outstanding shares voting in favor of the merger. The proposed merger is expected to close on or around February 22, 2021.About ZAGG IncZAGG Inc (NASDAQ: ZAGG) is a global leader in accessories and technologies that empower mobile lifestyles. The Company has an award-winning product portfolio that includes screen protection, mobile...

SAN DIEGO, Feb. 18, 2021 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced the European Commission (EC) has granted orphan designation to sparsentan for the treatment of IgA nephropathy (IgAN), a rare kidney disorder and a leading cause of end-stage kidney disease (ESKD). Sparsentan is an investigational product candidate currently being evaluated in a pivotal Phase 3 clinical study for the treatment of IgAN, as well as a pivotal Phase 3 clinical study for the treatment of focal segmental glomerulosclerosis (FSGS). The Company recently reported that the ongoing DUPLEX Study of sparsentan in FSGS achieved its pre-specified interim proteinuria endpoint and that preliminary results from the interim analysis suggest that to date in the study, sparsentan has been generally well-tolerated and has shown a comparable...

BRIDGEWATER, N.J., Feb. 18, 2021 (GLOBE NEWSWIRE) — Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a fully integrated biopharmaceutical company, announced today that Brian Markison, Chief Executive Officer, and Andrew Einhorn, Chief Financial Officer, will present at the 10th Annual SVB Leerink Global Healthcare Conference as follows:About Osmotica Pharmaceuticals plcOsmotica Pharmaceuticals plc (Nasdaq: OSMT) is a fully integrated biopharmaceutical company focused on the development and commercialization of specialty products that target markets with underserved patient populations. The company has a diverse portfolio consisting of promoted and non-promoted products, several of which incorporate Osmotica’s proprietary Osmodex® drug delivery system. RVL Pharmaceuticals, Inc. is the Company’s ophthalmic...

PORTLAND, Maine, Feb. 18, 2021 (GLOBE NEWSWIRE) — Northeast Bank (the “Bank”) (NASDAQ: NBN) announced today the passing on February 14 of the Chairman of its Board of Directors, Robert R. Glauber. Mr. Glauber had served as Chairman of the Board since 2010, Chair of the Bank’s Governance Committee and a member of its Compensation Committee.Rick Wayne, President and Chief Executive Officer of the Bank, said “We are deeply saddened by the passing of Bob, who led our Board with a steady hand, a sharp mind and absolute integrity. He led by example and was a role model for all of us at Northeast Bank. Our most heartfelt condolences go out to his wife, his two children and their spouses, his friends, colleagues, and students around the world. He will be missed.”Mr. Glauber was a tenured professor at Harvard Business School at the start...